Synapse - Dana Haviland

Results (16)

Cross validation of the monoclonal antibody Das-1 in identification of high-risk mucinous pancreatic cystic lesions

Journal Article

Das, K. K.; Geng, X.; Brown, J. W.; Morales-Oyarvide, V.; Huynh, T.; Pergolini, I.; Pitman, M. B.; Ferrone, C.; Al Efishat, M.; Haviland, D.; more...
Gastroenterology (2019)

Fulltext@MSK | Save

Should patients with cystic lesions of the pancreas undergo long-term radiographic surveillance? Results of 3024 patients evaluated at a single institution

Conference Paper

Lawrence, S. A.; Attiyeh, M. A.; Seier, K.; Gönen, M.; Schattner, M.; Haviland, D. L.; Balachandran, V. P.; Kingham, T. P.; D'Angelica, M. I.; DeMatteo, R. P.; more...
Lippincott Williams & Wilkins (2017)

Fulltext@MSK | Save

Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated carcinomas (≤ 20-mm invasive component): A multi-institutional analysis

Journal Article

Winter, J. M.; Jiang, W.; Basturk, O.; Mino-Kenudson, M.; Ven Fong, Z.; Tan, W. P.; Lavu, H.; Vollmer, C. M.; Furth, E. E.; Haviland, D.; more...
Annals of Surgery (2016)

Fulltext@MSK | Save

Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?

Meeting Abstract

Kemeny, N. E.; Schwartz, L. H.; Gonen, M.; Yopp, A. C.; D'Angelica, M. I.; Fong, Y.; Haviland, D.; Gewirtz, A. N.; Allen, P. J.; Jarnagin, W. R.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Antiangiogenic therapy for primary liver cancer: Correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response

Journal Article

Yopp, A. C.; Schwartz, L. H.; Kemeny, N.; Gultekin, D. H.; Gonen, M.; Bamboat, Z.; Shia, J.; Haviland, D.; D'Angelica, M. I.; Fong, Y.; more...
Annals of Surgical Oncology (2011)

Fulltext@MSK | Save

Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?

Journal Article

Kemeny, N. E.; Schwartz, L.; Gonen, M.; Yopp, A.; Gultekin, D.; D'Angelica, M. I.; Fong, Y. M.; Haviland, D.; Gewirtz, A. N.; Allen, P.; more...
Oncology (2011)

Fulltext@MSK | Save

A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies

Journal Article

Tse, A. N.; Wu, N.; Patel, D.; Haviland, D.; Kemeny, N.
Cancer Chemotherapy and Pharmacology (2009)

Fulltext@MSK | Save

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer

Journal Article

Kemeny, N.; Capanu, M.; D'Angelica, M.; Jarnagin, W.; Haviland, D.; DeMatteo, R.; Fong, Y.
Annals of Oncology (2009)

Fulltext@MSK | Save

Regional chemotherapy for unresectable primary liver cancer: Results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival